Zivo Bioscience Financing
Zivo Bioscience, Inc., Corporation just released form D regarding $5.00 million equity and debt financing. This is a new filing. Zivo Bioscience was able to finance itself with $1.25 million so far. That is 25.00% of the financing round. The total offering amount was $5.00 million. The private financing document was filed on 2016-10-14. The reason for the financing was: There are also up to 7.5 million warrants of common stock available. The fundraising still has about $3.75 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Zivo Bioscience is based in Michigan. The filler’s business is Other Health Care. The form was signed by Philip M Rice II CFO. The company was incorporated more than five years ago. The filler’s address is: 2804 Orchard Lake Road, Suite 202, Keego Harbor, Mi, Michigan, 48320. Philip Rice Ii is the related person in the form and it has address: 2804 Orchard Lake Rd, Ste 202, Keego Harbor, Mi, Michigan, 48320. Link to Zivo Bioscience Filing: 000107878216003648.
Analysis of Zivo Bioscience Offering
On average, firms in the Other Health Care sector, sell 68.60% of the total offering size. Zivo Bioscience sold 25.00% of the offering. The fundraising is still open. The average investment size for companies in the Other Health Care industry is $1.16 million. The total amount raised is 7.76% bigger than the average for companies in the Other Health Care sector. The minimum investment for this financing is set at $50000. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Zivo Bioscience Also
The Form D signed by Philip M Rice II might help Zivo Bioscience, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.